ENZON PHARMACEUTICALS INC's ticker is ENZN and the CUSIP is 293904108.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2014 | $15,000 | -63.4% | 14,073 | -64.2% | 0.00% | – |
Q2 2014 | $41,000 | +2.5% | 39,311 | 0.0% | 0.00% | – |
Q1 2014 | $40,000 | -13.0% | 39,311 | 0.0% | 0.00% | – |
Q4 2013 | $46,000 | -64.3% | 39,311 | -48.9% | 0.00% | – |
Q3 2013 | $129,000 | -39.4% | 76,860 | -27.8% | 0.00% | – |
Q2 2013 | $213,000 | – | 106,456 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Baupost Group | 4,337,858 | $5,032,000 | 0.14% |
PRICE MICHAEL F | 748,200 | $868,000 | 0.11% |
ALGERT GLOBAL LLC | 124,891 | $145,000 | 0.04% |
Rotella Capital Management, Inc. | 13,701 | $16,000 | 0.03% |
Icahn Capital | 5,904,863 | $6,850,000 | 0.02% |
Spark Investment Management LLC | 110,100 | $127,000 | 0.02% |
FCG ADVISORS, LLC | 20,000 | $23,000 | 0.02% |
BRANDES INVESTMENT PARTNERS, LP | 1,023,893 | $1,188,000 | 0.02% |
GLOBEFLEX CAPITAL L P | 101,454 | $117,000 | 0.01% |
BOGLE INVESTMENT MANAGEMENT L P /DE/ | 129,089 | $149,000 | 0.01% |